← All people
Congress
Brandon Williams
Congressional disclosures describe the filer and reportable household transactions, with amounts in ranges.
Source last checked 2026-10-12 01:31 UTC. Reporting dates appear with the records.
Stock growth & value
Stocks linked to collected disclosures. Prices refresh in the background; the chart shows its actual price dates.
No linked stock prices yet
We need a mapped security from a disclosure before showing stock growth. Public posts alone do not establish a portfolio or investment return.
Congressional transactions
Showing 3 of 3 disclosed transactions. Amounts are reported ranges; family ownership stays attributed.
| Asset | Action | Amount range | Date |
|---|---|---|---|
| F S: New L: US D: Shareholder distribution as a result of Visant Medical merger with Amring Pharmaceuticals Visant Medical, Inc. [PS]self | sell | $1K – $15K | 2024-06-03 |
| I P O C S my knowledge and belief. Further, I CERTIFY that I have disclosed all transactions as required by the STOCK Act. Digitally Signed: 2000121516 * For the complete list of asset type abbreviations, please visit https://fd.house.gov/reference/asset-type-codes.aspx. I CERTIFY that the statements I have made on the attached Periodic Transaction Report are true, complete, and correct to the best of Yes No Hon. Brandon McDonald Williams , 07/10/2024 F S: Amended L: US D: Shareholder distribution as a result of Visant Medical merger with Amring Pharmaceuticals Visant Medical, Inc. [PS] https://fd.house.gov/reference/asset-type-codes.aspxself | sell | $1K – $15K | 2024-02-01 |
| I P O C S my knowledge and belief. Further, I CERTIFY that I have disclosed all transactions as required by the STOCK Act. Digitally Signed: * For the complete list of asset type abbreviations, please visit https://fd.house.gov/reference/asset-type-codes.aspx. I CERTIFY that the statements I have made on the attached Periodic Transaction Report are true, complete, and correct to the best of Yes No Hon. Brandon McDonald Williams , 07/02/2024 F S: New L: US D: Shareholder distribution as a result of Visant Medical merger with Amring Pharmaceuticals Visant Medical, Inc. [PS] https://fd.house.gov/reference/asset-type-codes.aspxself | sell | $1K – $15K | 2023-02-01 |